The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study to evaluate the safety and efficacy of BB-1701 in subjects with HER2 expression locally advanced/metastatic breast cancer previously treated with HER2-ADC containing TOP-I inhibitor.
 
Xiaoxiang Guan
No Relationships to Disclose
 
Yehui Shi
No Relationships to Disclose
 
Jin Yang
No Relationships to Disclose
 
Fei Xu
No Relationships to Disclose
 
Huihui Li
No Relationships to Disclose
 
Wenhui Wang
No Relationships to Disclose
 
Xinhong Wu
No Relationships to Disclose
 
Xin Zhou
No Relationships to Disclose
 
Yunjiang Liu
No Relationships to Disclose
 
Haijun Yu
No Relationships to Disclose
 
Wenhui Guo
No Relationships to Disclose
 
Huoling Tang
Employment - Bliss Biopharmaceutical
 
Xiangzhu Tian
Employment - Bliss Biopharmaceutical
 
Yuhong Zhou
Employment - Bliss Biopharmaceutical
 
Ziping Wei
Employment - Bliss Biopharmaceutical